ML20039F616
| ML20039F616 | |
| Person / Time | |
|---|---|
| Site: | 05000545 |
| Issue date: | 12/29/1981 |
| From: | Rahe E WESTINGHOUSE ELECTRIC COMPANY, DIV OF CBS CORP. |
| To: | Harold Denton Office of Nuclear Reactor Regulation |
| References | |
| NS-EPR-2537, NUDOCS 8201130151 | |
| Download: ML20039F616 (1) | |
Text
l
. gg-CVJ-i
\\
U Westinghouse Water Reactor Nucien TechnologyDivision Electric Corporation Divisions D
sacss F.ECEIVED Pittsburgh Pennsylvania 1523J 3
g 5
JAN111982* h December 29, 1981 7/ a munnumetamma t)
N888 7 "
NS-EPR-2537 1)
//
16 Mr. Harold R. Denton, Director Office of Nuclear Reactor Regulations U.S. Nuclear Regulatory Com:nission 7920 Norfolk Avenue Bethesda, Maryland 20014
SUBJECT:
Request for Extension of the RESAR-3S Preliminary Design Approval
Dear Mr. Denton:
With regard to RESAR-3S, the Reference Safety Analysis Report for the Westing-house 3411 MWt Nuclear Steam Supply System, Westinghouse had submitted addi-tional information for a two-year extension of PDA-7 with letter NS-TMA-2179 dated December 18, 1979. This two-year extension will end this December 31, 1981. Because of the continued interest in a standardization program for the nuclear power industry, Westinghouse would like to keep the RESAR-3S PDA-7 administrative 1y active and not be allowed to expire.
Although this PDA does not directly address current licensing requirements for new applications (e.g., TMI Action Plan), there do exist significant aspects and technical areas that would not require re-review or change. The resultant benefits in both resource and time required by a regulatory review and Westinghouse'are significant.
It is requested that the Nuclear Regulatory Commission therefore provide an additional two-year administrative extension to PDA-7. Referencing this PDA would be' contingent upon addressing significant new safety issues raised since the TMI-2 accident.
Very truly yours,
--m p
. Rahe, Jr., Manager Nuclear Safety Department WRS/bek fB05 61l0 8201130151 8'11229 '
El^
PDR ADOCK 05000545 J
A PDR
_ _ _ _